Asthma biologic effectiveness by age and sex in the US CHRONICLE study
Biologic therapies reduce asthma exacerbations in adults with severe asthma, regardless of age or sex. These findings support the use of biologics in diverse patient populations.
Authors
- Jennifer Trevor (ORCID: https://orcid.org/0000-0001-6072-6274)
- Alan P. Baptist (ORCID: https://orcid.org/0000-0001-8284-0027)
- Njira Lucia Lugogo (ORCID: https://orcid.org/0000-0002-0235-7105)
- Mathieu Pelletier
- Donna Carstens
- Christopher S. Ambrose (ORCID: https://orcid.org/0000-0003-4175-7336)
- Weily Soong (ORCID: https://orcid.org/0000-0002-2701-7035)
- Bradley E. Chipps (ORCID: https://orcid.org/0009-0000-7857-9225)
Institutions
- Henry Ford Health System (US)
- University of Michigan (US)
- Henry Ford Hospital (US)
- University of Alabama at Birmingham (US)
- Capital Allergy and Respiratory Disease Center (US)
- Laboratoire Roberval (FR)
- AstraZeneca (Switzerland) (CH)
- AstraZeneca (Italy) (IT)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.jacig.2025.100589
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00